Drug Trafficking
Drug trafficking is the illegal trade in controlled substances, covering activities such as growing, producing, moving, distributing, and selling drugs that are subject to prohibition. It is a global illicit trade and a significant source of revenue for organised crime groups, which are often involved in other serious crimes as well. In an anti-money laundering context, it is significant because the profits generated typically need to be laundered to appear legitimate.
Drug trafficking refers, in criminal-law terms, to the illegal cultivation, manufacture, transportation, distribution, and sale of controlled substances subject to drug prohibition. The specific conduct and controlled substances captured vary by jurisdiction: under US federal law, for example, Title 21, Section 841 makes it unlawful to distribute or transact in controlled substances, while other regimes define trafficking offences through their own national statutes. From a financial crime compliance perspective, drug trafficking commonly serves as a predicate offence for money laundering, generating illicit proceeds that criminal organisations may seek to place, layer, and integrate into the legitimate financial system. Obliged entities generally treat exposure to drug trafficking proceeds as a heightened money laundering risk factor, though the precise designation as a predicate offence, and any applicable thresholds or reporting obligations, should be confirmed against the relevant national AML framework.
Why it matters
Drug trafficking is among the most significant proceeds-generating predicate offences underpinning money laundering worldwide. Because the trade in controlled substances is conducted largely in cash and across borders, criminal organisations must find ways to disguise the origin of their profits before those funds can be used or invested. This creates a direct link between drug trafficking and the money laundering activity that AML programmes are designed to detect, deter, and manage. For obliged entities, exposure to potential drug trafficking proceeds is typically treated as a heightened money laundering risk factor warranting closer scrutiny.
The threat is amplified by the fact that drug trafficking rarely exists in isolation. As noted by the UK National Crime Agency, drug trafficking is a major source of revenue for organised crime groups, many of which are involved in other forms of serious crime such as firearms offences. This convergence means that financial flows connected to drug trafficking may also intersect with other predicate offences, complicating detection and increasing the reputational, regulatory, and legal risks faced by firms that inadvertently process such proceeds.
It is important to distinguish the criminal-law dimension from the compliance dimension. The offence itself is defined by national statute, and whether particular conduct constitutes trafficking depends on the applicable jurisdiction. From a compliance standpoint, the relevance lies in drug trafficking's status as a predicate offence for money laundering. However, an alert, a suspicious transaction, or a pattern consistent with drug proceeds does not by itself establish that any underlying crime has occurred; such indicators inform risk-based decisions and, where appropriate, reporting, rather than proving wrongdoing.
Who it's relevant to
Inside Drug Trafficking
Common questions
Answers to the questions practitioners most commonly ask about Drug Trafficking.